Do You Want to Start a Company? or Lessons from Babs’s Excellent Adventure Babs Soller, PhD Founder, President & Chief Scientific Officer Reflectance Medical.

Slides:



Advertisements
Similar presentations
Welcome to the Open Court Business Plan Executive Summary Template!
Advertisements

Creating a Winning E-Business Second Edition Getting Your E-Business Off The Ground Chapter 4.
Title Slide Name of your business Your name or presenter’s name
DO YOU WANT TO BE AN ENTREPRENEUR?. WHAT IT TAKES Starting your own business may sound exciting, but it is not something to take on lightly. Do some soul.
So you want to start a company? A Guide for UMass Faculty, Researchers and Students.
Story of AntiOp, Inc. (f/k/a Alcomed, Inc.) Daniel Wermeling, Pharm.D. President and CEO Professor of Pharmacy University of Kentucky College of Pharmacy.
Technology and Economic Development Intellectual Property Issues in Research Jim Baker Director Office of Technology and Economic Development
IP Issues in Research Jim Baker, Executive Director Innovation, and Industry Engagement.
How to Pitch Angel Investors By Stephen Van Beaver 01/09/14.
Chapter 13 Communicating the Opportunity. Objectives Target the business to investors. Prepare oral and visual presentation for investors. Investor evaluation.
University Technology Transfer Presentation to Legislative Biotechnology Task Force 29 September 2005 Gene A. Merrell Assistant Vice President - Research.
Module 4 The Search for Capital. Module 4 Topics Sources of Capital Background Start-up Ongoing Operations Growth.
Biotechnology The Israeli Case Definition Using living organisms, cells or biological agents, to produce goods and services. Modern biotechnology arose.
Starting a Company from Research at the UW James A. Severson, Ph.D. Vice Provost, Intellectual Property and Technology Transfer January 30, 2007.
Students to Start-ups Entrepreneurial Skills Workshop Series The Les Kilpatrick.
Board of Directors Meeting February 2014 Scott Marland, PhD BioInnovations Gateway Executive Director Some thoughts on Product Development.
Venture Capital Colgate Finance Club C.J. Onis 30 October 2011.
Commercialization of University Technology Innovation, Technology Transfer and Licensing Jack Turner, Associate Director M.I.T. Technology Licensing Office.
Presented by: TBIN, Inc. The Business & Investment Network busnetwk.com (631)
Equity Financing for High Growth
Copyright (C) 2011, EDUMETRIX INC. 1 Fund  G r o w  SELL Your Business Context John J. Stuppy, MBA, Ph.D
Financing Your Venture It is not as hard as you think!
Getting Your E-Business off the Ground Chapter 5.
George McAllister ext The SBTDC is a business advisory service of The University of North Carolina System operated.
PROJECT ON PRIVATE EQUITY, VENTURE CAPITAL, CREDIT RATING AGENCY, SEBI AND RBI Presented by: Dharmil C. Gosalia PG Abhijit D. Shah PG
ZSX Medical Financing Questions Given the “total” amount of money ZSX needs to reach FDA clearance, are they best served by: 1.Seeking the money as proposed.
CEO Ventures Entrepreneur Resources... How Do Venture Capitalists Select Investments? Full content credits to Catharine Merigold.
The Funding Process From The Entrepreneur’s Perspective Dan Dykens CEO Norbury Financial Systems, LLC.
Tm&i 2010 VIII.1 technology management & innovation technology start-up companies: sources of funding & the business plan.
BZUPAGES.COM Aasma Yasmeen Roll no: BS(IT) 7 th semester.
VENTURE CAPITAL FINANCING. VENTURE CAPITAL – Some Views General Georges Doriot – father of US Venture Capital “Venture Capital is Patient and Brave Money.
Entrepreneurship and Small-Business Ownership
Entrepreneurship & Small Business Management 10/2/
Funding a start-up: How to raise your first round Jayan Ramankutty Founder/CEO YuMe Networks BITSAA.org, June 25 th 2006.
Cover Life Cycle of Financing 8 South Michigan Suite 400 Chicago, IL p (312) f (312) Linda.
Getting Your E-Business off the Ground Chapter 5.
1 Entrepreneurship and Small Business Management.
Enterpreneurship: Commercializing Technolgies Taking Research from the Lab to the Real World: Is Having a Good Idea Enough? Dorothy H. Air, PhD Associate.
Hampton Consulting Ltd. Entrepreneurship & Venture Capital (VC) Investment A Risky Business?
1 Rutgers Sponsored Research and Technology Transfer Michael Breton, Ph.D Associate Vice President for Research.
Managing Conflicts of Interest at the IRB and Institutional Level: INSTITUTIONAL CONFLICTS OF INTEREST Claudia R. Adkison, J.D., Ph.D. Executive Associate.
World Intellectual Property Organization DCPPS 1 presented by Mr. Vladimir Yossifov WIPO NATIONAL WORKSHOP ON INNOVATION SUPPORT SERVICES AND THEIR MANAGEMENT.
Ch 15 Raising Capital. 1. Financing life cycle of a firm: Early stage financing and venture capital Usually people with ideas contact banks at first.
Stephanie McCoy March 9, I.Venture Capital Process II.Venture Capital Investing Trends III.Industry Compensation IV.Dos and Don’ts Agenda.
Ignite Technology Transfer NUI Galway Technology Transfer Office Seamus Coyne, Ph.D Neil Ferguson, Ph.D Commercialisation Executives Technology Transfer.
 Updated – Separated - Linked  One-stop business consulting.
MOEA SMEA APEC 2009 SME Innovation Seminar Innovation in SME Financing and Marketing Session II: Establishing a Market – based Economic Environment Su,
Commercialization Plan Product Development Business model Financial plan BUSINESS PLAN Development strategy Budgets IDEA Invention Preface Fig 1.
Small Business Innovation Research Program (SBIR) Presented by Sharina Broughton.
Culture Shift! For Active Commercialization Cliff Zintgraff UTEN UT-Austin © 2007 Cliff Zintgraff & UTEN UT-Austin.
1 SBIR/STTR Overview Wang Yongqiang. 2 Federal SBIR/STTR Program ‣ A +$2Billion funding program set-aside for small businesses seeking to early stage.
Startup Name Business Plan v.1. Problem/solution Tell a story, be creative, help investors understand the pain and why the solution is needed If investors.
Pitch Deck If attending Pitch Coaching, you will only need: 1)Problem 2)Solution 3)Revenue Model 4)Market Opportunity This is a template only. Your pitch.
Small Business Innovation Research Small Business Technology Transfer Research Prepared by: Susan Malone Back, PhD, MBA Director, SBIR/STTR Resource Center.
Building the Best Team that Delivers and that Investors Love TEAMWORK MAKES THE DREAM WORK:
Small Business Innovation Research & Small Business Technology Transfer Dr. Peter Atherton SBIR/STTR Program Director The National Science Foundation.
1 Communicating with Venture Capitalists to Fund Your Research Raising Venture Capita l Michael Jirousek, Ph.D. Senior Advisor, Innovation Support Center.
Introduction to Entrepreneurship: It’s All About The Money, Right? By: Venture Highway.
from an idea to an IPO ashok devata, EMC From cradle to riches
Technology Transfer Office
Jesus Soriano, MD, PhD, MBA SBIR/STTR Program Director
Foresight Science & Technology, Inc.
Financing Small Firm Innovation in the United States
Universities and the Commercial World
Panel 8: Corporations and startups: universities bridging the gap
Name Project / Organization
MTECH Technology Entrepreneurship Activities
Capital Advisory and Management Consulting
MONETIZING IP and TECH TRANSFER The Patent Attorney’s Perspective
Proposal Presentation to the
Presentation transcript:

Do You Want to Start a Company? or Lessons from Babs’s Excellent Adventure Babs Soller, PhD Founder, President & Chief Scientific Officer Reflectance Medical Inc. Prof Emeritus of Anesthesiology, UMass Medical School

How does it start? There has to be an important unmet need 1.Standard vital signs are inadequate in identifying patients in compensated shock. 2.Standard vital signs are not sufficient as guides to resuscitation. 3.The solution has to be small, lightweight, portable, noninvasive and easy for first responders to use. This problem was presented in a grant solicitation from the US Army in 1995 and it’s still a huge unmet need.

The big idea

Why a company? Needed money to build hardware and develop software. Medical products require clearance from the FDA before they can be sold. A corporate framework is needed to achieve this. Large monitoring companies rarely support research into new vital signs, only investing after the company has brought the product to market and shown acceptance by the medical community.

The first product: CareGuide Oximeter (2012)

Starting a company 1.Protect your technology with patents. 2.The right time to think about a company. 3.Begin to develop your business plan. 4.Getting help. 5.Decide how involved you want to be. 6.Sources of funding. 7.Landmines. 8.Last words.

1. Protect your technology with patents Novel technology should be protected by US and in many cases international patents. When you receive federal research support you have an obligation to disclose the invention to your employer, who reports it to the funding agency. Under the Bayh-Dole act, UMass owns, or is assigned the rights to the invention. The UMass Office of Technology Management oversees the patenting process.

Patents continued UMass can choose to proceed with a patent application, or give the technology back to you. Under the Bayh-Dole Act, universities can profit from inventions made under federal research grants and most seek to license patents to private entities. Patents are the currency of commercial investment. A patent portfolio can be the basis of a start-up company.

2. The right time to start thinking about a company For medical devices –Working prototype –Some clinical data –Good idea about the market

3. Begin to develop your business plan Market –Unmet clinical need –Market size (> $1 billion for VC investment) –How your technology will address target market Competition –Who else is out there and why you are different and better. Technical –How your invention works, written for someone with no technical background. Intellectual property –Issued and pending patents.

Business plan continued Regulatory –The FDA regulations you have to meet to sell your product and your strategy to achieve them. Business model –How you are going to make money with your technology? –What it is you are actually going to sell and for how much? Sales and marketing –Who’s going to sell it? –To whom are you going to sell it? –How are you going to convince them to buy it? –Sales projections.

Business plan continued Reimbursement –Who’s going to pay for the product when you sell it? Management team –Key personnel with expertise in all areas of the business plan, or plan on how & when you will get it. Use of funds –Your expenses. –Key milestones that add value to the company Exit strategy –How is the investor going to make a profit on their investment?

4. Getting help to get started At UMass –Office of Technology Management –Massachusetts Technology Transfer Center –M2D2: Massachusetts Medical Device Development Center Local, national and international entrepreneur groups –In MA:, MassMEDIC IGNITE, MIT Enterprise Forum, MedDevice Group –SBIR/STTR education sessions –TiE

find a good mentor to work with you Well connected. –Can help you fill out your team with experienced professionals (CEO, regulatory, marketing, manufacturing). –Make introductions to potential investors. Has extensive experience with start-up companies. Knows your market and technical space. Understands the issues working with universities. Someone you can call to ask stupid questions.

5. How involved to you want to be? License your technology to a large company and wave goodbye. License your technology to a large or small company with a consulting contract or sponsored research agreement. Start your own company. all approaches require you to articulate your product and the market

6. Sources of funding – getting started University programs –Small grants, resources for prototypes, access to clinicians – business plan competitions State & local programs –Matching funds –Loans –Incubators Federal programs –CCAT, Navy funded program

Sources of funding – serious money – you need a company SBIR/STTR grants – one of the few types of federal grants that can be used for commercialization activities –Every federal agency (percentage of their budget) –Phase I: $100K, usually 6 months –Phase II: $750K, usually 2 years –NIH has more flexible rules Angel investors & angel groups –~$100K to $1-$2 million –Angel investors often provide mentoring –Bridge to venture funding Venture capitalists (VC’s) –Few to tens of million dollars –Early stage VC’s mentor entrepreneurs

7. Landmines Conflict of interest. –make sure you understand the policies –Individual & institution conflicts –Financial and human subject conflicts Bad advice is plentiful, trust your sources. Understand early, what is required to obtain your FDA approval. Understand the financial transactions and how they impact you. Raising money for commercialization takes a lot longer than you think.

8. Last words Excitement is important, if you are excited about your technology, so will prospective investors. Investors will “give you the science”. They have confidence that you will get the technology to work. Investors want you to be successful, because that’s how they make money. They will help you. A “business plan” is really 30 powerpoint slides. Consultants, lawyers and CEOs who work with entrepreneurs may initially work without pay in exchange for equity & an opportunity to work with an exciting start up company.

Last words, really It really is an adventure, take the plunge! Contact Info: Babs Soller, PhD Reflectance Medical Westboro, MA x223